Significant Ownership of Gates Frontier, LLC

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Gates Frontier, LLC focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Alan Heuberger - Attorney-in-fact for Michael Larson, Manager
Manager location
Kirkland, WA

Follow Filing Activity

Follow Gates Frontier, LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of Gates Frontier, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYEL Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share 5.6% $10,628,242 1,040,964 Gates Frontier, LLC 25 Jul 2025
EVLV Evolv Technologies Holdings, Inc. Class A common stock, par value $0.0001 per share 1.4% $19,776,951 2,365,664 Gates Frontier, LLC 18 Sep 2025

Schedules 13D/G Reported by Gates Frontier, LLC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .